Article
Time Passages: Bruce Goldsmith out at Jim Wilson's gene therapy biotech; Flagship reveals Michael Severino's CEO gig
Rating:
0.0
Views:
113
Likes:
1
Library:
1
→ When Passage Bio readjusted its pipeline priorities, pruned its workforce by 13% and saw its R&D chief Eliseo Salinas walk out in March, it would be natural to assume that this confluence of events could lead to more imminent changes. This week, CEO Bruce Goldsmith followed Salinas and board
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value